EVAX - Evaxion Biotech A/S

QQQ $ 592.57 $ 5.24 (0.89 %)

DIA $ 463.14 $ 3.67 (0.8 %)

SPY $ 660.59 $ 5.58 (0.85 %)

TLT $ 89.46 $ -0.21 (-0.23 %)

GLD $ 373.27 $ -0.76 (-0.2 %)

Previous Close

$ 5.34

Open

$ 5.25

Bid

$ 5.12 x 14

Ask

$ 5.19 x 100

Day's Range

$ 4.85 - $ 5.29

52 Week Range

$ 1.20 - $ 12.15

Volume

177,849

Average Volume

Market Cap

374.5M

Beta (5Y Monthly)

$ 4.99

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Evaxion Advances Multi-Component Cytomegal...
11/20/2025 13:04:29

Evaxion's AI-Immunology™ platform has discovered novel CMV antigens that significantly reduce viral infection in preclinica...

Evaxion Announces New Data Exploring Immun...
11/07/2025 22:16:58

Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunology™ power...

Evaxion Biotech Q3 EPS $0.01 Beats $(0.21)...
11/06/2025 12:32:10

Evaxion Biotech (NASDAQ:EVAX) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.2...

Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

What's Next: Evaxion Biotech's Earnings Pr...
11/05/2025 20:02:43

Evaxion Expands R&D Pipeline With Addition...
11/03/2025 14:10:44

Evaxion introduces EVX-04, a novel vaccine candidate targeting multiple non-conventional ERV tumor antigens, developed with our...

this-draganfly-analyst-begins-coverage-on-a-bullish-note-here-are-top-3-initiations-for-thursday

This Draganfly Analyst Begins Coverage On ...
10/30/2025 13:32:17

Edward Jones Initiates Coverage On Evaxion...
10/30/2025 12:55:42

Edward Jones analyst Soumit Roy initiates coverage on Evaxion (NASDAQ:EVAX) with a Buy rating and announces Price Target of ...

Evaxion Says Has Raised $7.2M In Recent We...
10/30/2025 12:08:06

Evaxion A/S Appoints Helen Tayton-Martin C...
10/27/2025 12:05:27

Evaxion A/S (NASDAQ: EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunology™ powe...

Lake Street Maintains Buy on Evaxion, Rais...
10/20/2025 13:16:06

Lake Street analyst Thomas Flaten maintains Evaxion (NASDAQ:EVAX) with a Buy and raises the price target from $6 to $11.

HC Wainwright & Co. Reiterates Buy on Evax...
10/20/2025 12:01:59

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Evaxion (NASDAQ:EVAX) with a Buy and maintains $16 price t...

12 Health Care Stocks Moving In Friday's A...
10/17/2025 21:07:13

12 Health Care Stocks Moving In Friday's I...
10/17/2025 17:05:58

Evaxion A/S Reports Two-Year Phase 2 Data ...
10/17/2025 12:21:34

Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunology™ power...

12 Health Care Stocks Moving In Wednesday'...
10/15/2025 17:07:00

Evaxion Will Present Comprehensive Phase 2...
10/13/2025 12:09:35

Presentation will cover two-year clinical efficacy, immunogenicity and safety dataData will be presented at an oral session on ...

12 Health Care Stocks Moving In Tuesday's ...
10/07/2025 17:06:17

Evaxion To Present New Biomarker And Immun...
10/03/2025 13:02:29

12 Health Care Stocks Moving In Friday's A...
09/26/2025 21:06:04

Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of t...